These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9385108)

  • 1. A parametric multistate model for the analysis of carcinogenicity experiments.
    Omar RZ; Stallard N; Whitehead J
    Lifetime Data Anal; 1995; 1(4):327-46. PubMed ID: 9385108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating the magnitude of carcinogenic effects in long-term animal studies.
    Stallard N; Whitehead A
    Hum Exp Toxicol; 1995 Aug; 14(8):643-53. PubMed ID: 7576831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constant risk differences in the analysis of animal tumorigenicity data.
    Dinse GE
    Biometrics; 1991 Jun; 47(2):681-700. PubMed ID: 1912267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of tumour incidence analyses applicable in single-sacrifice animal experiments.
    Dinse GE
    Stat Med; 1994 Mar 15-Apr 15; 13(5-7):689-708. PubMed ID: 8023043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating multiple tumor transition rates based on data from survival-sacrifice experiments.
    Lu Y; Malani HM
    Math Biosci; 1994 Jul; 122(1):95-125. PubMed ID: 8081051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flexible multistate models for interval-censored data: Specification, estimation, and an application to ageing research.
    Machado RJM; van den Hout A
    Stat Med; 2018 May; 37(10):1636-1649. PubMed ID: 29383740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biostatistical issues in the design and analysis of animal carcinogenicity experiments.
    Portier CJ
    Environ Health Perspect; 1994 Jan; 102 Suppl 1(Suppl 1):5-8. PubMed ID: 8187725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dose-response test via closed-form solutions for constrained MLEs in survival/sacrifice experiments.
    Kim W; Ahn H; Moon H
    Stat Med; 2007 Feb; 26(3):694-708. PubMed ID: 16596576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling tumor onset and multiplicity using transition models with latent variables.
    Dunson DB; Haseman JK
    Biometrics; 1999 Sep; 55(3):965-70. PubMed ID: 11315036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of historical controls in time-adjusted trend tests for carcinogenicity.
    Ibrahim JG; Ryan LM
    Biometrics; 1996 Dec; 52(4):1478-85. PubMed ID: 8962464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A semi-Markov multistate model for estimation of the mean quality-adjusted survival for non-progressive processes.
    Tunes-da-Silva G; Pedroso-de-Lima AC; Sen PK
    Lifetime Data Anal; 2009 Jun; 15(2):216-40. PubMed ID: 19082710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Joint modeling of progression-free and overall survival and computation of correlation measures.
    Meller M; Beyersmann J; Rufibach K
    Stat Med; 2019 Sep; 38(22):4270-4289. PubMed ID: 31273817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ratio estimates, the delta method, and quantal response tests for increased carcinogenicity.
    Bieler GS; Williams RL
    Biometrics; 1993 Sep; 49(3):793-801. PubMed ID: 8241374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parametric multistate survival models: Flexible modelling allowing transition-specific distributions with application to estimating clinically useful measures of effect differences.
    Crowther MJ; Lambert PC
    Stat Med; 2017 Dec; 36(29):4719-4742. PubMed ID: 28872690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Permutational distribution of the log-rank statistic under random censorship with applications to carcinogenicity assays.
    Heimann G; Neuhaus G
    Biometrics; 1998 Mar; 54(1):168-84. PubMed ID: 9544515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weighted multiplicity adjustments for animal carcinogenicity tests.
    Westfall PH; Soper KA
    J Biopharm Stat; 1998 Mar; 8(1):23-44; discussion 45-53. PubMed ID: 9547426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of associations between diseases in animal carcinogenicity experiments.
    Mitchell TJ; Turnbull BW
    Biometrics; 1990 Jun; 46(2):359-74. PubMed ID: 2364126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proportional hazards regression of survival-sacrifice data with cause-of-death information in animal carcinogenicity studies.
    Mao L
    Stat Med; 2019 Aug; 38(19):3628-3641. PubMed ID: 31074119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multistate additive relative survival semi-Markov model.
    Gillaizeau F; Dantan E; Giral M; Foucher Y
    Stat Methods Med Res; 2017 Aug; 26(4):1700-1711. PubMed ID: 26056059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of continuous- and discrete- time three-state models for rodent tumorigenicity experiments.
    Lindsey JC; Ryan LM
    Environ Health Perspect; 1994 Jan; 102 Suppl 1(Suppl 1):9-17. PubMed ID: 8187731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.